An announcement from Cogstate Ltd ( (AU:CGS) ) is now available.
Cogstate Ltd has announced an update on its ongoing on-market buy-back program, revealing that a total of 2,785,408 ordinary fully paid securities have been bought back prior to the previous day, with an additional 41,606 securities acquired on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides digital cognitive assessment tools and services, primarily targeting clinical trials, academic research, and healthcare markets.
YTD Price Performance: 29.48%
Average Trading Volume: 9,624
Technical Sentiment Signal: Sell
Current Market Cap: $151.2M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.